CD4+CD25+FoxP3+ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease

被引:213
作者
Chen, Xinchun
Zhou, Boping
Li, Meizhong
Deng, Qunyi
Wu, Xueqiong
Le, Xiaohua
Wu, Chi
Larmonier, Nicolas
Zhang, Wei
Zhang, Hongmei
Wang, Huosheng
Katsanis, Emmanuel
机构
[1] Shenzhen Donghu Hosp, Shenzhen 518020, Peoples R China
[2] Univ Arizona, Steele Childrens Res Ctr, Dept Pediat, Tucson, AZ 85724 USA
[3] Guangdong Med Coll, Affiliated Shenzhen Hosp 3rd, Inst Hepatol, Shenzhen 518020, Peoples R China
[4] TB Ctr, Hosp PLA 309th, Beijing 100091, Peoples R China
基金
中国国家自然科学基金;
关键词
Mycobacterium tuberculosis; CD4(+)CD25(+)FoxP3(+) regulatory T cells; pulmonary tuberculosis;
D O I
10.1016/j.clim.2006.11.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T cells (Treg) play a central role in the prevention of autoimmunity and in the control of immune responses by down-regulating the function of effector CD4(+) or CD8(+) T cells. The role of Treg in Mycobacterium tuberculosis infection and persistence is inadequately documented. Therefore, the current study was designed to determine whether CD4(+)CD25(+)FoxP3(+) regulatory T cells may modulate immunity against human tuberculosis (TB). Our results indicate that the number of CD4(+)CD25(+)FoxP3(+) Treg increases in the blood or at the site of infection in active TB patients. The frequency of CD4(+)CD25(+)FoxP3(+) Treg in pleural. fluid inversely correlates with local MTB-specific immunity (p < 0.002). These CD4(+)CD25(+)FoxP3(+) T lymphocytes isolated from the blood and pleural fluid are capable of suppressing MTB-specific IFN-gamma and IL-10 production in TB patients. Therefore, CD4(+)CD25(+)FoxP3(+) Treg expanded in TB patients suppress M. tuberculosis immunity and may therefore contribute to the pathogenesis of human TB. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:50 / 59
页数:10
相关论文
共 44 条
[1]   Cell-mediated immune responses and cytotoxicity to mycobacterial antigens in patients with tuberculous pleurisy in Brazil [J].
Arruda, S ;
Chalhoub, M ;
Cardoso, S ;
Barral-Netto, M .
ACTA TROPICA, 1998, 71 (01) :1-15
[2]   Interleukin-10 therapy - Review of a new approach [J].
Asadullah, K ;
Sterry, W ;
Volk, HD .
PHARMACOLOGICAL REVIEWS, 2003, 55 (02) :241-269
[3]  
BARNES PF, 1989, J IMMUNOL, V142, P1114
[4]   Natural regulatory T cells in infectious disease [J].
Belkaid, Y ;
Rouse, BT .
NATURE IMMUNOLOGY, 2005, 6 (04) :353-360
[5]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[6]   IL-10-producing T cells suppress immune responses in anergic tuberculosis patients [J].
Boussiotis, VA ;
Tsai, EY ;
Yunis, EJ ;
Thim, S ;
Delgado, JC ;
Dascher, CC ;
Berezovskaya, A ;
Rousset, D ;
Reynes, JM ;
Goldfeld, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1317-1324
[7]   Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program [J].
Chieppa, M ;
Bianchi, G ;
Doni, A ;
Del Prete, A ;
Sironi, M ;
Laskarin, G ;
Monti, P ;
Piemonti, L ;
Biondi, A ;
Mantovani, A ;
Introna, M ;
Allavena, P .
JOURNAL OF IMMUNOLOGY, 2003, 171 (09) :4552-4560
[8]   Global epidemiology of tuberculosis [J].
Dye, C .
LANCET, 2006, 367 (9514) :938-940
[9]  
Ferrer J, 1997, EUR RESPIR J, V10, P942
[10]   Immunology of tuberculosis [J].
Flynn, JL ;
Chan, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :93-129